IAAEX
Price
$11.56
Change
-$0.31 (-2.61%)
Updated
Dec 18 closing price
VEVYX
Price
$45.61
Change
-$1.51 (-3.20%)
Updated
Dec 18 closing price
Ad is loading...

IAAEX vs VEVYX

Header iconIAAEX vs VEVYX Comparison
Open Charts IAAEX vs VEVYXBanner chart's image
Transamerica Mid Cap Value Opps I2
Price$11.56
Change-$0.31 (-2.61%)
VolumeN/A
CapitalizationN/A
Victory Sycamore Established Value Y
Price$45.61
Change-$1.51 (-3.20%)
VolumeN/A
CapitalizationN/A
IAAEX vs VEVYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IAAEX vs. VEVYX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IAAEX is a Hold and VEVYX is a Sell.

FUNDAMENTALS
Fundamentals
VEVYX has more cash in the bank: 18.7B vs. IAAEX (1.17B). VEVYX pays higher dividends than IAAEX: VEVYX (1.26) vs IAAEX (0.96). IAAEX was incepted earlier than VEVYX: IAAEX (11 years) vs VEVYX (12 years). IAAEX is a more actively managed with annual turnover of: 44.00 vs. VEVYX (28.00). IAAEX has a lower initial minimum investment than VEVYX: IAAEX (0) vs VEVYX (1000000). IAAEX (2.92) and VEVYX (2.80) have marching annual gain over last year. VEVYX return over 5 years is better than : 24.70 vs. IAAEX (-0.39).
IAAEXVEVYXIAAEX / VEVYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years12 years-
Gain YTD6.0552.420250%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.17B18.7B6%
Annual Yield % from dividends0.961.2676%
Returns for 1 year2.922.80105%
Returns for 3 years-20.862.53-825%
Returns for 5 years-0.3924.70-2%
Returns for 10 years10.0938.4026%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATXI1.840.18
+10.84%
Avenue Therapeutics
PRPH0.700.01
+1.33%
ProPhase Labs
CMPR75.49-3.04
-3.87%
Cimpress plc
OTEX27.37-1.26
-4.40%
Open Text Corp
CAPR12.52-0.68
-5.15%
Capricor Therapeutics